Abstract
Telomeres are transcribed from the telomeric C-rich strand, giving rise to UUAGGG repeat-containing telomeric transcripts or TERRA, which are novel structural components of telomeres. TERRA abundance is highly dependent on developmental status (including nuclear reprogramming), telomere length, cellular stresses, tumour stage and chromatin structure. However, the molecular mechanisms and factors controlling TERRA levels are still largely unknown. In this study, we identify a set of RNA-binding proteins, which endogenously bind and regulate TERRA in the context of primary mouse embryonic fibroblasts. The identification was carried out by biotin pull-down assays followed by LC-MALDI TOF/TOF mass spectrometry. Different members of the heterogeneous nuclear ribonucleoprotein family are among the ribonucleoprotein family that bind more abundantly to TERRA. Downregulation of TERRA-bound RBPs by small interfering RNA further shows that they can impact on TERRA abundance, their location and telomere lengthening. These findings anticipate an impact of TERRA-associated RBPs on telomere biology and telomeres diseases, such as cancer and aging.
Similar content being viewed by others
Introduction
Telomeres are specialized heterochromatin structures at the ends of eukaryotic chromosomes that prevent chromosome ends from being recognized as DNA double-strand breaks1,2. In vertebrates, telomeres are composed of TTAGGG repeats bound by a six-protein complex known as shelterin3,4. Despite the long-standing belief that telomeres were transcriptionally inactive because of their compact heterochromatin structure, two independent reports recently showed that telomeres are transcribed5,6. In particular, the telomeric C-rich strand is transcribed by the DNA-dependent RNA polymerase II, giving rise to UUAGGG-repeat transcripts known as TERRA/TelRNAs (referred hereafter as TERRA)5,6. TERRA are non-coding RNAs, heterogeneous in size (ranging between 100 bp and 9 kb) and formed by a combination of subtelomeric and telomeric sequences5,6. To date, transcripts containing telomeric repeats have been described in Mus musculus, Homo sapiens, Saccharomyces cerevisiae and Danio rerio5,6,7. TERRA have been detected at telomeres, as indicated by their co-localization with shelterin components such as TRF15,6, suggesting that TERRA are novel structural components of telomeres. TERRA levels are modulated by a number of factors, including telomeric chromatin status, cellular stresses, as well as during ontogenesis and cancer6. More recently, TERRA abundance was shown to be tightly regulated during nuclear reprogramming of differentiated cells into induced pluripotent stem cells, highlighting the importance of TERRA regulation during the acquisition of a pluripotent state (Marion et al8; reviewed in Schoeftner and Blasco9). Until recently, however, the trans-acting factors (for example, RNA-binding proteins (RBPs), miRNAs, and so on) and the mechanisms controlling TERRA levels remained unaddressed. A recent report described the shelterin protein TRF2 as a novel TERRA-interacting protein, thereby facilitating heterochromatin formation and recruitment of the replication–initiation ORC complex to telomeres10.
Previous reports suggested that RBPs are important for telomere biology. In particular, members of the heterogeneous nuclear ribonucleoprotein family (hnRNPs), which participate in many aspects of mRNA maturation/turnover, have been proposed to regulate both telomere length and telomerase. Among these, hnRNP A1, A2B1, A3, D (also known as AUF1) and E can associate with the single-stranded telomeric repeats, and hnRNP A1 has been shown to influence telomere length11,12,13 (reviewed in Ford et al.14). In addition, hnRNP A1, D and C1/C2 were shown to interact with human telomerase12,15,16,17,18. The hnRNP proteins can also affect chromatin remodelling and transcription in a DNA-independent manner through protein–protein interactions (for example, hnRNP U binds RNA polymerase II) (reviewed in Carpenter et al.19). The hnRNP A1 and D have been also implicated in transcription owing to their ability to bind to and unwind G-quadruplexes18,20. A role for hnRNP A1 in transcription that does not involve unwinding of G-quadruplexes has been also reported21. Another group of RBPs, known to bind to small nucleolar RNAs, including GAR1 and dyskerin, has also been found to interact and regulate telomerase in vivo22,23. Here, we report the identification of the RBPs bound to TERRA in primary mouse embryonic fibroblasts (MEFs). We found that hnRNPs are the RBPs that bind more abundantly to TERRA. Furthermore, we show that these RBPs regulate TERRA abundance as well as TERRA location to telomeres. Moreover, downregulation of TERRA-bound RBPs can impact on telomere length and DNA damage at telomeres.
Results
Identification of TERRA-bound RBPs in primary MEFs
Here, we carried out an unbiased analysis searching for the specific set of RBPs that bind to mouse TERRA. To identify the TERRA-bound RBPs, we performed biotin pull-down assays using a biotinylated transcript consisting of eight UUAGGG repeats (8×UUAGGG) and nuclear extracts from primary MEFs. Two mass spectrometry (MS) approaches were used for the identification of RBPs after pull-down assays (1) liquid chromatography–matrix-assisted laser desorption/ionisation–tandem MS (LC-MALDI-MS/MS) analysis of pull-down material and (2) matrix-assisted laser desorption/ionisation–time of flight/time of flight–MS (MALDI TOF/TOF-MS) analysis of excised bands obtained after SDS–polyacrylamide gel electrophoresis (SDS–PAGE) separation and Coomassie staining of pull-down material. A biotinylated control RNA corresponding to a random sequence of the same length as the biotinylated TERRA (N48) was used for differential identification in both approaches. The first approach led to the identification of some 41 candidates that were bound only to the biotinylated TERRA and not to the control RNA (Table 1). More than 50% of the identified candidates possess known RNA-binding domains (Table 1) and locate predominantly in the nucleus. Interestingly, some of the identified RBPs have been previously reported to participate in regulation of telomeres and telomerase, as mentioned above. In particular, hnRNP A1, A2B1 and D/AUF1 bind to telomeres11,12,13 (reviewed in Ford et al.14) and hnRNP A1, D and GAR1 bind to telomerase12,15,16,22. The second approach allowed the identification of those RBPs that bind more abundantly to the biotinylated TERRA (Fig. 1). Importantly, the proteins identified by this second approach were among those identified by the first approach, confirming the robustness of their interaction with TERRA. Virtually, all the RBPs identified by the second approach belonged to the hnRNP family, including hnRNP A1, A2/B1, M and F, by order of abundance (Fig. 1). While in preparation of this manuscript, a different group independently found that hnRNP A1, A2/B1 and M bound to human TERRA transcripts10, although this interaction was not further characterized in the paper. Here, we set out to show the in vitro and in vivo binding of these proteins to TERRA and to study their role in TERRA regulation and telomere biology.
The hnRNPs bind to TERRA in vitro and in vivo
We first performed biotin pull-down assays followed by western blot using specific antibodies against hnRNP A1, A2B1, F and M to confirm our protein identification results (Fig. 2a). Because of the labile nature of TERRA (half-life of ∼3 h), we also tested for the presence of hnRNP D/AUF1 (which was identified by the first approach; Table 1) and of HuR in TERRA. Both hnRNP D/AUF1 and HuR belong to the AU-rich binding protein family, and are the best-studied RBPs implicated in controlling mRNA turnover (reviewed in Brennan and Steitz24, Barreau et al.25 and Guhaniyogi and Brewer26). As shown in Figure 2a, hnRNP A1, A2B1, F, M, D/AUF1 and HuR formed complexes only with the biotinylated TERRA and not with the control RNA. The RBP vigilin served to monitor the evenness of sample input, as it was identified in both 8×UUAGGG and control (N48) samples by LC-MALDI (Fig. 2a). Quantification of the TERRA signal/input ratio signal showed that hnRNP A1 and hnRNP F are the RBPs more abundantly bound to TERRA (Fig. 2a).
Next, we conducted in vivo binding assays to test association of the RBPs to endogenous TERRA. To this end, we isolated RNA from RBP-immunoprecipitated (IP) material (Supplementary Fig. S1) followed by northern blot hybridization using a specific probe to detect TERRA transcripts. As shown in Figure 2b, TERRA signal was detected in HuR-, hnRNP A1-, A2B1-, M-, D- and F-IPs and not in control immunoglobulin G (IgG)-IP samples, showing the in vivo binding of these RBPs to TERRA. Collectively, these results indicate that TERRA are bound in vivo by a complex set of RBPs in which different members of the hnRNP family are the most abundant ones.
TERRA-bound RBPs influence TERRA abundance and location
To assess the functional consequences of RBP-TERRA interactions, we first measured TERRA levels after knocking down expression of RBPs. This was achieved by transient transfection of primary MEFs with specific small interfering RNAs (siRNAs) against the different RBPs identified here. We were able to knockdown RBPs proteins to ∼10–50% of the levels present in primary MEFs transfected with a control siRNA (Fig. 3a). We next measured TERRA levels by northern blot analysis using total RNA from siRNA-transfected MEFs (Fig. 3b). For all of the siRNAs against TERRA-interacting RBPs tested here, lowering of RBP expression by 10–50%, showed a tendency to increase TERRA steady-state levels compared with control-transfected cells, this difference was more dramatic in hnRNP F, M and D/AUF1 knockdowns and reached statistical significance in the case of hnRNP F knockdown (Fig. 3b; see also Supplementary Fig. S2a). These results indicate that hnRNP F may act as a potent repressor of TERRA levels. This repression might be linked to the known role of hnRNP F as a negative regulator of pre-mRNA cleavage, which is needed for the polyadenylation steps27. In particular, hnRNP F downregulation may result in increased polyA+-TERRA contributing to augmented protection of 3′ end of TERRA from exonucleases, which in turn could increase TERRA stability and the observed increase in TERRA levels. We could not detect clear changes in the extent of polyadenylation after hnRNP F knockdown as compared to C siRNA (Supplementary Fig. S2). However, the interpretation of these results should be taken with caution given the heterogeneity in TERRA size, as well as the fact that TERRA levels also change upon RBPs siRNAs (Fig. 3b and Supplementary Fig. S2). For these reasons, we next focused on studying changes in mRNA stability. We determined TERRA half-life (t1/2) after treatment with actinomycin D, which inhibits de novo transcription. Interestingly, knockdown of hnRNP F increased the half-life of TERRA to an estimated t1/2 > 8 h compared with t1/2=5.7 h in the control-transfected cells (Fig. 3c). Of interest, we observed a reproducible increase in TERRA levels at the 4-h time point of actinomycin D treatment, which could be associated to a transient stabilization of TERRA due to the translocation of stabilizing RBPs to the cytoplasm on actinomycin D treatment (for example, see HuR translocation in Supplementary Fig. S3a). As a control for the former treatment, we measured the half-life of the labile c-fos mRNA by reverse transcriptase quantitative PCR in parallel with the half-life of a stable transcript, the GAPDH mRNA28. As expected, the c-fos mRNA decayed rapidly on actinomycin D incubation, with a half-life of 1.5 h, whereas GAPDH mRNA decayed at slower rates, with a half-life of 7 h (Supplementary Fig. S3b). Note that c-fos mRNA, a target of HuR28, also becomes stabilized at the 4-h time point. Interestingly, the TERRA half-life value falls in between the half-life of the labile mRNA, c-fos (t1/2=1.51 h), and the stable mRNA, GAPDH (t1/2=7.07 h) (Supplementary Fig. S3b). Different increases in TERRA stability were also observed on downregulation of the other TERRA-bound RBPs (Supplementary Fig. S4). As some of the hnRNPs are known to participate in the nuclear export of mRNAs19,29, we also tested the possibility of changes in the subcellular localization of TERRA on the siRNAs of RBPs. TERRA remained nuclear (Supplementary Fig. S5), in agreement with their reported presence restricted to the nuclear compartment when TERRA were first described5,6. Collectively, these results suggest that hnRNP F represses TERRA levels, at least in part, by reducing the stability of TERRA transcripts and this effect is probably independent of TERRA polyadenylation status.
To ascertain whether TERRA-bound RBPs could regulate TERRA location to telomeres, we performed immunofluorescence staining using antibodies against the TRF1 telomeric protein followed by RNA-fluorescence in situ hybridization (RNA-FISH) to detect TERRA (Fig. 4). Interestingly, downregulation of hnRNP M and D/AUF1, and to a lower extent, hnRNP F and A2B1, caused a significant increase in TERRA foci co-localizing with TRF1, suggesting that these hnRNPs can block the location of TERRA to telomeres (Fig. 4). As both hnRNP M and D/AUF1 have been previously shown to bind to single-stranded DNA11,20,30, absence of these two hnRNPs from telomeres may activate a mechanism that recruits TERRA to telomeres, possibly to increase telomere protection (see Fig. 5 for decreased telomere damage foci in hnRNP M and D/AUF knockdowns).
Impact of TERRA-bound RBPs on telomere damage and length
Next, we set out to assess the potential role of TERRA-bound hnRNPs in telomere protection by studying the presence of telomeric 53BP1 DNA damage foci (TIFs) after knockdown of the different RBPs. Although we did not detect significant differences in global DNA damage (see percentage of cells showing 53BP1 foci in Fig. 5a and b), we detected a significant increase in telomere-co-localizing 53BP1 foci (TIF) on knocking down hnRNP A1, F and, to a lesser extent, when hnRNP A2B1 and HuR were targeted (Fig. 5a and c), indicative of increased telomere damage. Downregulation of hnRNP M and D/AUF1, however, did not lead to increased number of TIFs with respect to control cells. Interestingly, these two knockdowns were those that showed a more dramatic accumulation of TERRA to telomeres (Fig. 4). These results suggest that the TERRA-bound RBPs may contribute to protect telomeres from eliciting a DNA damage response, and that to achieve this it is not sufficient to have increased TERRA levels or low mobilization to telomeres (as seen for hnRNP F siRNA;Figs 3b and 4), but a massive mobilization of TERRA to telomeres is also required (as in the case of hnRNP M and D siRNAs; Fig. 4). To ascertain whether changes in shelterin components contributed to the increased number of TIFs on downregulation of TERRA-interacting RBPs, we measured TRF1 and RAP1, two of the shelterin components, by immunofluorescence (Supplementary Fig. S6). We did not observe significant changes in the co-localization of these two proteins except for an increase in the case of hnRNP M knockdown, in agreement with a higher TERRA localization to telomeres (Fig. 4) and a very low abundance of TIFs in these cells (Fig. 5a and c). Finally, we also detected a decrease in RAP1/TRF1 co-localization events on hnRNP F knockdown, which may contribute to the high abundance of TIFs or uncapped telomeres present in these cells (Fig. 5c).
Next, we addressed whether knockdown of the TERRA-interacting RBPs identified here resulted in altered telomere length. As shown in Figure 6a and b, knockdown of the different TERRA-interacting RBPs resulted in a significant increase in the average telomere length in the case of hnRNP A1, F, and M knockdowns. Furthermore, short telomeres were significantly decreased on downregulation of most TERRA-bound RBPs, except for HuR and hnRNP A2B1 (differences on hnRNP A2B1 knockdown did not reach significance) (Fig. 6a and c). These effects on telomere length were dependent on the telomerase status, as downregulation of TERRA-bound RBPs in first generation telomerase-deficient G1 Terc−/− MEFs31 did not result in an increase in the average telomere length on hnRNP A1, F and M knockdowns and did not decrease the presence of short telomeres, as observed on similar knockdowns in wild-type littermates (Fig. 6).
Discussion
Recent studies have revealed that non-coding RNAs containing UUAGGG repeats, named TERRA, are transcribed from telomeres that were largely thought to be transcriptionally inactive5,6. Several biological processes as well as cellular stresses have been described to influence TERRA levels and their nuclear localization and accumulation including the telomeric chromatin stage, telomere length, heat shock, exogenously inflicted DNA damage, as well as ontogenesis and cancer6,8,32 (reviewed in Schoeftner and Blasco9). However, the TERRA-bound factors controlling all of these processes remain largely unknown. A recent report described a number of proteins bound to TERRA in human cancer cells, including the telomere repeat-binding factor, TRF2, which was further shown to have a role in TERRA regulation. Here, we identify in primary MEFs a number of TERRA-interacting RBPs. In particular, we find that members of the hnRNPs, the ones that more abundantly bind to TERRA, influence TERRA levels by regulating the stability of the transcripts. Some of them also influence TERRA location at telomeres, which confers protection from telomeric DNA damage. Furthermore, knockdown experiments for each of the identified TERRA-bound RBPs also show a common role of hnRNPs on the telomerase-dependent elongation of short telomeres.
While in preparation of this paper, a fraction of the TERRA-bound RBPs identified here in primary MEFs were also independently identified as TERRA-interacting proteins in human cancer cells, although they were not further studied by the authors10. These RBPs belong to the hnRNP family (hnRNP A1, A2/B1, M and U). The fact that members of the hnRNP family bind to both human and mouse TERRA suggest conservation among species and might be indicative of critical roles of hnRNPs in TERRA regulation. We show here that hnRNP A1, A2/B1, M and F are the proteins that bind more abundantly to TERRA, and they do so both in vitro and in vivo. The hnRNPs constitute a large family of proteins that were first found to be associated with nascent pre-mRNAs, packaging them into hnRNP particles. The hnRNPs particles were immunopurified by Dreyfuss' and co workers30 in 1988 and are composed of an assortment of at least 24 polypeptides designated as hnRNP A1 to hnRNP U. The structural diversity of these proteins accounts for a multitude of functions that involve interactions with DNA or, more commonly, RNA. Most of them, if not all, are indeed single-stranded nucleic acid-binding proteins (preferentially RNA)30 although with different nucleotide preference (for example, hnRP A1 and A/B bind to UUAGGG sequences, whereas hnRNP F favours XGGGX sequences). These binding preferences are in agreement with the binding of, for instance, hnRNP A1, A2/B1 and F to TERRA transcripts, which are composed of UUAGGG repeats. The hnRNPs are multifunctional and have been implicated in a wide variety of processes such as transcription, RNA processing, translation and signal transduction events (reviewed in Carpenter et al.19). These proteins have also been associated with telomere biology because of their direct binding to telomeres, their interaction with the telomerase and their effect on telomere lengthening. In particular, hnRNP A1, A2B1, A3, D and E can associate with the single-stranded telomeric repeats, although only hnRNP A1 has been shown to influence telomere length11,12,13 (reviewed in Ford et al.14). The hnRNP A1, D and C1/C2 are also able to interact with human telomerase12,15,16,17,18 and hnRNP A1 and D can unwind G-quadruplexes18,20. The hnRNP interaction with TERRA transcripts and the effects on TERRA and telomeres that we described here further support a central role of hnRNPs in telomere biology. Thus, we found that hnRNPs regulate TERRA abundance and localization, as well as influence telomere length. A direct effect of the hnRNPs on this process might be envisioned, as these proteins interact directly with TERRA, telomeres and telomerase10,11,12,13,15,16,17,18 and because of the rapid effects observed 2-days on knockdowns, for instance, on the elimination of short telomeres. However, because of the cellular abundance of hnRNPs and their pleiotropic roles, we also expect global cellular changes on hnRNP knockdowns and, therefore, we cannot exclude the contribution of secondary players on the observed effects on TERRA and telomeres.
Loss-of-function experiments described here suggest individual, as well as common roles for each of the different hnRNPs in TERRA and telomere regulation. In particular, we found that hnRNP F acts as a repressor of TERRA levels, at least in part, through the destabilization of the telomeric transcripts, although other transcriptional and post-transcriptional mechanisms cannot be discarded19. A different role was observed for hnRNP M and D. These two RBPs seem to block the access of TERRA transcripts to telomeres, as their downregulation increases the number of TERRA foci at telomeres. As discussed below, the mobilization of TERRA to telomeres maybe needed to protect telomeres when they become uncapped. We also found an apparent rescue of cells with short telomeres on knocking down most of the TERRA-interacting RBPs, which was dependent on the presence of telomerase. Although we cannot rule out that downregulation of TERRA-interacting RBPs may lead to elimination of cells with the shortest telomeres because of global effects of the knockdowns, these results may also suggest that hnRNP may influence either telomerase activity or the accessibility of telomerase to telomeres. Interestingly, some of the hnRNPs have been described to interact with human telomerase12,15,16,17,18.
In addition, the results described here suggest a protective role of TERRA when mobilized massively to telomeres. In particular, although downregulation of TERRA-bound RBPs resulted in a significant increase in telomere dysfunction-induced foci (TIFs), such as in the case of hnRNP A1 and F, probably because of telomere uncapping (hnRNP A1, A2/B1 and D are known to bind single-stranded telomeric repeats), downregulation of hnRNP M and D, which strongly increased the mobilization of TERRA to telomeres, significantly protected them from TIF induction. These results suggest a protective role of TERRA at telomeres, which is in agreement with recent results showing that TERRA downregulation leads to increased TIFs10.
Together, the results presented here show that TERRA transcripts are bound by a complex set of proteins, being hnRNP A1, A2B1, F and M the most abundant ones. In the past, different observations led to propose a model in which hnRNPs act as a molecular bridge or a linker to recruit telomerase to telomeres14,17,29. In light of our new findings that hnRNPs bind to TERRA transcripts, thereby affecting both their levels and their location, we would like to suggest additional levels of regulation to this model in which hnRNPs have distinct and common roles in TERRA stability, telomere protection and telomere length regulation.
Methods
Cell culture and siRNA transfections
The MEFs were obtained from wild-type embryos and G1 Terc-null embryos33 at embryonic day E13.5, as previously described31. The target sequence for siRNA was 5′-AAGAGGCAATTACCAGTTTCA-3′ for HuR, 5′-ATGGATCAGAAAGAACATAAA-3′ for AUF1, 5′-CCACTTAACTGTGAAAAAGAT-3′ for hnRNP A1, 5′-AAGCTTTGAAACCACAGAAGA-3′ for hnRNP A2B1, 5′-AAACTTGTTACCTTCCATTAA-3′ for hnRNP F, 5′-ATGGAAGATGCTAAAGGACAA-3′ for hnRNP M and 5′-AATTCTCCGAACGTGTCACGT-3′ for control (C) siRNA; siRNAs (1.5 μg, Qiagen) were nucleofected with Amaxa system (Lonza), according to manufacturers' protocol, and cells were harvested 2 days later.
Protein identification by MS
Two MS approaches were used for identification of RBPs after pull-down assay: LC-MALDI-MS/MS analysis of pull-down material and MALDI TOF/TOF-MS analysis of excised bands obtained after SDS–PAGE separation and Comassie staining of pull-down material. A biotinylated control RNA corresponding to a random sequence of the same length (N48) as the biotinylated TERRA was used for differential identification.
For protein identification from pull-down material, beads from six replicated assays were pooled and washed twice with ice-cold 25 mM ammonium bicarbonate. Bound proteins were chemically reduced by the addition of 20 μl of 10 mM DL-dithiothreitol at 65 °C for 1 h and alkylated by 50 mM iodoacetamide at room temperature in the dark for 30 min. Proteolytic digestion was then performed with 125 ng trypsin (Trypsin Gold, Promega) in 25 mM ammonium bicarbonate, with overnight incubation at 37 °C in a final volume of 50 μl. The reaction was stopped by adding 1 μl of 10% heptafluorobutyric acid. Digested samples were analyzed by LC-MALDI-MS/MS. Peptides were trapped into a 200 μm×5 mm monolithic capillary columns based on poly-(styrene/divinylbenzene) (PS-DVB) (PepSwift, LC-Packings) previously equilibrated in 0.065% heptafluorobutyric acid in water. Desalted peptides were separated on a 200 μm×50 mm PS-DVB column, using a lineal gradient from 100% buffer A (0.055% trifluoroacetic acid (TFA) in water) to 60% buffer B (0.055% TFA in 50% acetonitrile (v/v)) for 40 min at 2.5 μl min−1 at 60 °C. A total of 416 five-second fractions were spotted on a stainless steel plate together with 2.5 mg ml−1 α-cyano-4-hydroxycinnamic acid in 50% acetonitrile/0.1% TFA (v/v) and 5 mM ammonium dihydrogenphosphate, containing 10 fmol μl−1 Glu-fibrinopeptide (MW=1570.668 Da), as internal standard. Samples were subjected to MALDI MS/MS analysis using a 4800 Proteomics Analyzer equipped with TOF-TOF ion optics (Applied Biosystems/MDS Analytical Technologies) and 4000 Series Explorer V.3.5.1. The instrument was operated in positive ion reflector mode and calibrated with 25 fmol of Peptide Calibration Standard II mixture (Bruker Daltonik GmbH) and the above-mentioned Glu-fibrinopeptide as an internal standard. The laser power was set to 2,800 a.u. for MS and 3,600 a.u. for MS/MS with collision-induced dissociation on. MS spectra were acquired across the mass range of 700–3,600 Da, with a total accumulation of 2,000 laser shots and minimum S/N filter of 25 for precursor ion selection. MS/MS spectra were acquired for the 15 most abundant precursor ions, with a total accumulation of 4,000 laser shots for each precursor.
For in-gel protein identification, proteins were isolated by SDS gel electrophoresis stained with Coomassie brilliant blue and processed as given in Shevchenko et al.,34 and directly subjected to MALDI TOF/TOF-MS analysis.
All MS/MS spectra generated were analyzed using ProteinPilot Software V2.01 rev 67476, with the Paragon search algorithm for interrogating the International Protein Index mouse database (release 20090225), using a detected protein threshold >2, expressed as unused ProtScore, (confidence >99%). Protein data sets were compared using ProteinCenter Software (Proxeon Bioinformatics A/S).
Western blot analysis
Whole-cell lysates and nuclear lysates were prepared using RIPA buffer and RSB buffer (10 mM Tris–HCl (pH 7.5), 10 mM NaCl, 3 mM MgCl2 and inhibitors), respectively, as previously described35,36. Protein lysates were resolved by SDS–PAGE and transferred onto nitrocellulose membranes. Antibodies used were the following: hnRNP A1 (Sigma; 1:5000 dilution), HuR diluted in the ratio 1:1000 and hnRNP A2B1 diluted in the ratio 1:500 (Santa Cruz Biotechnology), hnRNP F diluted in the ratio 1:500 and hnRNP M clone 2A6 diluted in the ratio 1:1000 (Abcam), AUF1 (Upstate; 1:1000 dilution), and Vigilin (in-house; 1:1000 dilution). Following secondary antibody incubations, signals were visualized by enhanced chemiluminescence.
IP assay of RNP complexes
The IP assay was performed using nuclear extracts37, except that 100 million cells were used as starting material and the lysate supernatants were precleared for 30 min at 4 °C using 15 μg of IgG (Santa Cruz Biotechnology) and 50 μl of protein A-Sepharose beads (Sigma) that had been previously swollen in NT2 buffer (50 mM Tris (pH 7.4), 150 mM NaCl, 1 mM MgCl2 and 0.05% Nonidet P-40) supplemented with 5% bovine serum albumin. Beads (100 μl) were incubated (18 h, 4 °C) with 30 μg of antibody and then for 1 h at 4 °C with 3 mg of cell lysate. After extensive washes with NT2 buffer and digestion of proteins in the IP material38, the RNA was extracted and used to perform northern blot. Antibodies used were the similar to those used for western blot analysis, except for hnRNP F that was from Santa Cruz Biotechnology (clone N15).
Biotin pull-down analysis
Biotin pull-down assays were carried out as described39 by incubating 150 μg of nuclear lysate with 0.9 ng of biotinylated transcripts (Invitrogen) for 30 min at room temperature. A measure of 0.9 ng of total RNA was added as competitor. Complexes were isolated using streptavidin-conjugated Dynabeads (Dynal), and bound proteins in the pull-down material were analyzed either by MS or by western blotting. The biotinylated TERRA transcript consists of 8×UUAGGG; the control biotinylated transcripts consist of random RNA sequence not present in MEFs with the same length as that of TERRA transcript. See Western blot analysis section for antibodies used.
Northern blot
Total and nuclear RNA was isolated with Trizol or Trizol LS, respectively (Invitrogen) and northern blot analysis was performed using standard protocols. For detection of TERRA, random primer-labeled (Rediprime, GE Healthcare), a 1.6 Kb (TTAGGG)n cDNA insert excised from pNYH3 (kind gift from T. de Lange, Rockefeller University, NY), was used. Normalization of northern signals was performed with the 18S rRNA (Ambion). Northern signals quantification was carried out with ImageJ (NIH).
mRNA stability
Actinomycin D (5 μg ml−1) was added 2 days after siRNA transfection and total RNA was prepared at the time periods indicated; mRNA half-lives were calculated after quantifying dot-blot signals, normalizing to 18S rRNA levels, plotting on logarithmic scales and calculating the time period required for a given transcript to undergo a reduction to one-half of its initial abundance (at time zero, before adding actinomycin D).
Immunofluorescence and immunostainings combined with RNA-FISH
Cells grown on poly-L-lysine-coated coverslips (Becton Dickinson) were placed in cytobuffer (100 mM NaCl/300 mM sucrose/3 mM MgCl2/10 mM pipes (pH 6.8)) for 30 s, washed in cytobuffer with 0.5% Triton X-100 for 30 s, washed in cytobuffer for 30 s and then fixed for 10 min in 4% paraformaldehyde in phosphate-buffered saline (PBS). After washing with PBS, cells were blocked overnight at 4 °C in PBS containing 3% (w/v) bovine serum albumin, 0.1% Tween-20, 0.3 μg μl−1 tRNA (Invitrogen) and 0.8 μg ml−1 RNasin (Promega). Antibodies against mouse TRF1 (in-house, 1:500 dilution) were incubated in blocking solution for 60 min at 37 °C. The slides were washed twice in PBS Tween-20, overlaid with goat anti-rabbit IgG (Alexa 488; Invitrogen) diluted in the ratio 1:400 for 1 h in blocking solution at 37 °C, washed three times in PBS Tween-20 and post-fixed in 4% paraformaldehyde in PBS. The cells were dehydrated in 70, 80, 95 and 100% ethanol, air-dried and hybridized overnight at 37 °C with TERRA RNA probe in hybridization buffer (2× sodium saline citrate (SSC)/50% formamide). Slides were washed three times for 5 min in hybridization buffer at 39 °C, three times for 5 min in 2× SSC at 39 °C, 10 min in 1× SSC at 39 °C, 5 min in 4× SSC at room temperature, 5 min in 4× SSC containing 0.1% Tween-20 and DAPI (Molecular Probes) at room temperature and 5 min in 4× SSC at room temperature. Signals were visualized in a confocal ultraspectral microscope TCS-SP5 (Leica). RNA-FISH probe was generated by random priming (GE Healthcare) using the 1.6 Kb (TTAGGG)n cDNA (see 'Northern Blot') and Cy3-labelled dCTP (Amersham). When immunofluorescence only was carried out, the following antibodies were used: rabbit polyclonal 53BP1 antibody (Novus biological; 1:500 dilution), mouse monoclonal TRF1 antibody (Abcam; 1:200 dilution) and rabbit polyclonal RAP1 antibody (Bethyl; 1:200 dilution).
Telomere length using telomere quantitative FISH on metaphases
Telomere quantitative FISH on metaphases was performed as described40,41. The cutoff used in the determination of the percentage of short telomeres was determined by averaging the results obtained after subtracting the 25% percentile from the mean telomere length value in the different conditions.
Polyadenylation assays
A measure of 20 μg of total RNA was incubated with 60 pmol oligodT (Invitrogen) at 65 °C for 5 min followed by quick chill on ice for 5 min. Then, half of the sample was treated with 1 U of RNase H (Invitrogen) and the other half was left untreated. Both samples were incubated at 37 °C for 30 min and the digestion was stopped with EDTA. On RNA purification, changes in TERRA migration were detected by northern blot.
Additional information
How to cite this article: López de Silanes, I. et al. TERRA transcripts are bound by a complex array of RNA-binding proteins. Nat. Commun. 1:33 doi: 10.1038/ncomms1032 (2010).
References
de Lange, T. T-loops and the origin of telomeres. Nat. Rev. Mol. Cell. Biol. 5, 323–329 (2004).
Goytisolo, F. A. & Blasco, M. A. Many ways to telomere dysfunction: in vivo studies using mouse models. Oncogene 21, 584–591 (2002).
Liu, D., O'Connor, M. S., Qin, J. & Songyang, Z. Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins. J. Biol. Chem. 279, 51338–51342 (2004).
de Lange, T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19, 2100–2110 (2005).
Azzalin, C. M., Reichenbach, P., Khoriauli, L., Giulotto, E. & Lingner, J. Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 318, 798–801 (2007).
Schoeftner, S. & Blasco, M. A. Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat. Cell. Biol. 10, 228–236 (2008).
Luke, B. et al. The Rat1p 5′ to 3′ exonuclease degrades telomeric repeat-containing RNA and promotes telomere elongation in Saccharomyces cerevisiae. Mol. Cell 32, 465–477 (2008).
Marion, R. M. et al. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4, 141–154 (2009).
Schoeftner, S. & Blasco, M. A. A 'higher order' of telomere regulation: telomere heterochromatin and telomeric RNAs. EMBO J. 28, 2323–2336 (2009).
Deng, Z., Norseen, J., Wiedmer, A., Riethman, H. & Lieberman, P. M. TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol. Cell 35, 403–413 (2009).
Moran-Jones, K. et al. hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere. Nucleic Acids Res. 33, 486–496 (2005).
LaBranche, H. et al. Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nat. Genet. 19, 199–202 (1998).
Huang, P. R., Tsai, S. T., Hsieh, K. H. & Wang, T. C. Heterogeneous nuclear ribonucleoprotein A3 binds single-stranded telomeric DNA and inhibits telomerase extension in vitro. Biochim. Biophys. Acta 1783, 193–202 (2008).
Ford, L. P., Wright, W. E. & Shay, J. W. A model for heterogeneous nuclear ribonucleoproteins in telomere and telomerase regulation. Oncogene 21, 580–583 (2002).
Ford, L. P., Suh, J. M., Wright, W. E. & Shay, J. W. Heterogeneous nuclear ribonucleoproteins C1 and C2 associate with the RNA component of human telomerase. Mol. Cell. Biol. 20, 9084–9091 (2000).
Eversole, A. & Maizels, N. In vitro properties of the conserved mammalian protein hnRNP D suggest a role in telomere maintenance. Mol. Cell. Biol. 20, 5425–5432 (2000).
Fiset, S. & Chabot, B. hnRNP A1 may interact simultaneously with telomeric DNA and the human telomerase RNA in vitro. Nucleic Acids Res. 29, 2268–2275 (2001).
Zhang, Q. S., Manche, L., Xu, R. M. & Krainer, A. R. hnRNP A1 associates with telomere ends and stimulates telomerase activity. RNA 12, 1116–1128 (2006).
Carpenter, B. et al. The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim. Biophys. Acta 1765, 85–100 (2006).
Enokizono, Y. et al. Structure of hnRNP D complexed with single-stranded telomere DNA and unfolding of the quadruplex by heterogeneous nuclear ribonucleoprotein D. J. Biol. Chem. 280, 18862–18870 (2005).
Xia, H. Regulation of gamma-fibrinogen chain expression by heterogeneous nuclear ribonucleoprotein A1. J. Biol. Chem. 280, 13171–13178 (2005).
Dragon, F., Pogacic, V. & Filipowicz, W. In vitro assembly of human H/ACA small nucleolar RNPs reveals unique features of U17 and telomerase RNAs. Mol. Cell. Biol. 20, 3037–3048 (2000).
Mitchell, J. R., Wood, E. & Collins, K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402, 551–555 (1999).
Brennan, C. M. & Steitz, J. A. HuR and mRNA stability. Cell. Mol. Life Sci. 58, 266–277 (2001).
Barreau, C., Paillard, L. & Osborne, H. B. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res. 33, 7138–7150 (2005).
Guhaniyogi, J. & Brewer, G. Regulation of mRNA stability in mammalian cells. Gene 265, 11–23 (2001).
Veraldi, K. L. et al. hnRNP F influences binding of a 64-kilodalton subunit of cleavage stimulation factor to mRNA precursors in mouse B cells. Mol. Cell. Biol. 21, 1228–1238 (2001).
Peng, S. S., C. C., Xu, N & Shyu, A. B. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 17, 3461–3470 (1998).
He, Y. & Smith, R. Nuclear functions of heterogeneous nuclear ribonucleoproteins A/B. Cell Mol. Life Sci. 66, 1239–1256 (2009).
Pinol-Roma, S., Choi, Y. D., Matunis, M. J. & Dreyfuss, G. Immunopurification of heterogeneous nuclear ribonucleoprotein particles reveals an assortment of RNA-binding proteins. Genes Dev. 2, 215–227 (1988).
Blasco, M. A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25–34 (1997).
Schoeftner, S . et al. Telomere shortening relaxes X chromosomes-inactivation and forces globla transcriptome alterations. Proc. Natl Acad. Sci. USA 106, 19393–19398 (2009).
Blasco, M. A., Funk, W., Villeponteau, B. & Greider, C.W. Functional characterization and developmental regulation of mouse telomerase RNA. Science 269, 1267–1270 (1995).
Shevchenko, A., Tomas, H., Havlis, J., Olsen, J. V. & Mann, M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 1, 2856–2860 (2006).
Lopez de Silanes, I. et al. Identification and functional outcome of mRNAs associated with RNA-binding protein TIA-1. Mol. Cell Biol. 25, 9520–9531 (2005).
Lopez de Silanes, I., Quesada, M. P. & Esteller, M. Aberrant regulation of messenger RNA 3′-untranslated region in human cancer. Cell Oncol. 29, 1–17 (2007).
Lal, A. et al. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J. 23, 3092–3102 (2004).
Lopez de Silanes, I., Zhan, M., Lal, A., Yang, X. & Gorospe, M. Identification of a target RNA motif for RNA-binding protein HuR. Proc. Natl Acad. Sci. USA 101, 2987–2992 (2004).
Wang, W. et al. HuR regulates p21 mRNA stabilization by UV light. Mol. Cell. Biol. 20, 760–769 (2000).
Herrera, E., Samper, E. & Blasco, M. A. Telomere shortening in mTR-/- embryos is associated with failure to close the neural tube. EMBO J. 18, 1172–1181 (1999).
Samper, E., Goytisolo, F. A., Slijepcevic, P., van Buul, P. P. & Blasco, M. A. Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep. 1, 244–252 (2000).
Acknowledgements
We are indebted to Stefan Schöeftner for reagents and to Elsa Vera for statistical analysis. We thank Myriam Gorospe for advice and valuable discussion of the paper. We also thank Keith Ashman and Fernando García from the CNIO Proteomics Unit and Diego Megías from the CNIO Confocal Unit for RBP identification and for confocal image acquisition, respectively. We thank Luis E. Donate for paper preparation. I.L.S. is a 'Ramon y Cajal' senior scientist with funding from the FIS Programme (PI061653) from the Spanish Ministry of Science and Innovation. M.A.B.'s laboratory is funded by the Spanish Ministry of Innovation and Science (SAF2008-05384, Programme CONSOLIDER-INGENIO 2010 CSD2007-00017), the Regional Government of Madrid (GSSTEM-CM), the Spanish Association Against Cancer (AECC), the European Union (FP7-HEALTH-2007-A-201630/GENICA, FP7-HEALTH-2007-200950/TELOMARKER, FP7-HEALTH-2007-A-20088/MARKAGE) the European Research Council (ERC Advanced Grant G#232854), and by the Körber European Science Award.
Author information
Authors and Affiliations
Contributions
I.L.S. and M.A.B. designed the experiments and I.L.S. and M.S.A. carried out the experiments.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
Supplementary Figures S1–S6 (PDF 542 kb)
Rights and permissions
About this article
Cite this article
de Silanes, I., d'Alcontres, M. & Blasco, M. TERRA transcripts are bound by a complex array of RNA-binding proteins. Nat Commun 1, 33 (2010). https://doi.org/10.1038/ncomms1032
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/ncomms1032
This article is cited by
-
RTEL1 influences the abundance and localization of TERRA RNA
Nature Communications (2021)
-
BRCA1 binds TERRA RNA and suppresses R-Loop-based telomeric DNA damage
Nature Communications (2021)
-
TERRA Gene Expression in Gastric Cancer: Role of hTERT
Journal of Gastrointestinal Cancer (2021)
-
A Data Driven Model for Predicting RNA-Protein Interactions based on Gradient Boosting Machine
Scientific Reports (2018)
-
Spatiotemporal analysis with a genetically encoded fluorescent RNA probe reveals TERRA function around telomeres
Scientific Reports (2016)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.